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Background: Hypnotic drugs tend to be the dominant form of treatment of insomnia, but these come with a
number of reported side effects. Acupuncture has been studied as an alternative, resulting in a rising need for
methodological research towards verifying its efficacy as insomnia treatment.
Methods/Design: We describe a proposal for a single-center, patient-assessor-blinded, randomized controlled trial
with two parallel arms. A total of 38 patients complete screening tests at the first visit, are registered into the clinical
trial, and then randomly assigned to the experimental or sham control groups (19 patients for each group). All
subjects are clinical insomnia patients who score a 6 or above on the Pittsburgh Sleep Quality Index (PSQI) and
meet all inclusion criteria. All subjects are treated with acupuncture and intradermal acupuncture (IDA) three times
during the first week. Five sham acupoints are used in the control group. In the experimental group, five real
acupoints (PC6, SP6, HT7, KI6, and BL62) are used unilaterally in turn. Sham acupoints are over 1 cm away from each
real acupoint.
The primary outcomes are the scores on the Insomnia Severity Index (ISI) and PSQI. Secondary outcomes are
the sleep log, the Beck Depression Inventory (BDI), the State-Trait Anxiety Inventory (STAI), the World Health
Organization Quality of Life Abbreviated Version (WHOQOL-BREF), the Korean-Auditory Verbal Learning Test
(K-AVLT), the Digit Span Test (DS), Event Related Potentials (ERPs) and heart rate variability (HRV) to assess emotional
states, sleep quality, cognitive functioning, and electro-physiological changes.
Subjects are assessed at three time points: baseline, post-treatment and follow-up. The duration of the clinical trial
is 18 days.
Discussion: To study the enhancement of the effectiveness of acupuncture for insomnia, we test the intradermal
acupuncture method, which is performed continuously on the subject’s skin and stimulated at home by the subject
every night. In the trial, objective measurements including ERPs and HRV are used to evaluate states of cognition
and autonomic nervous system functioning and subjective self-report questionnaires assess insomnia symptoms.
‘Sham’ acupuncture points provided by STRICTA are used for the control group.
Trial registration: ClinicalTrials.gov: NCT01956760, registered 5 September 2013.
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Insomnia is commonly defined as a state of being disturbed
during daytime activities due to poor sleep quality caused
by difficulties in sleep initiation or maintenance despite
being in a proper sleep-inducing environment. According
to the International Classification of Sleep Disorders,
Second Edition (ISDC-2), insomnia can be categorized as
acute insomnia, inadequate sleep hygiene, psychophy-
siological insomnia (primary insomnia), idiopathic insom-
nia, paradoxical insomnia, and insomnia associated with a
medical condition [1]. Approximately 35% of adults ex-
perience insomnia at least once in their lives and almost
half suffer seriously. Several studies report that approxi-
mately 10% of adults are disrupted in their daily activities
due to chronic insomnia [2,3].
Benzodiazepines, nonbenzodiazepine sedatives, and
melatonin agonists are the primary pharmacological
treatments for insomnia. Secondary treatment includes
antidepressants, diphenhydramine, antipsychotics, and
barbiturates [4]. Although effective, these medications
often cause side effects such as residual daytime seda-
tion, drowsiness, dizziness, lightheadedness, cognitive
impairment, motor incoordination, and dependence [5].
The current most prevalent non-pharmacological the-
rapies for insomnia are sleep hygiene education [6] and
cognitive and behavioral psychotherapy, but such treat-
ments require long-term implementation [7].
The effect of acupuncture on insomnia is consistently
emerging as an alternative treatment for insomnia. In a
systematic review by Yeung et al., 20 randomized con-
trolled trials were analyzed to assess the effect of acu-
puncture on insomnia patients by comparing them with
control patients given a benzodiazepine, with results in-
dicating that acupuncture was more effective. The study,
however, has certain limitations including an undefined
criterion for diagnosis, lack of randomization or blinded
conditions, and small sample sizes [8]. Several other
studies investigate the effect on acupuncture as a treat-
ment for insomnia by comparing different acupuncture
therapies, the effects of using and not using moxa, and
comparison with placebo sleeping pills [9-11]. One of
these studies shows that auricular acupuncture therapy
is more effective for insomnia than two other therapies,
and another suggests that acupuncture therapy with
moxa is more effective than without [9,10]. Cheuk et al.,
in a review of 33 clinical trials on the effects of acupunc-
ture on insomnia, conclude that many trials indicate
acupuncture treatment improves quality of sleep, but fu-
ture trials need to be more methodologically rigorous,
and that extant trials may be prone to the risk of bias
coming from the definition of insomnia, participant
characteristics, acupoints, and treatment regimen [12].
Despite the number of studies related to acupuncture
and insomnia in the literature however, it is necessaryfor future trials to provide more methodologically sound
evidence of acupuncture’s effect.
It is also is important to include an assessment of
psychological/mood states, cognitive functions, and physio-
logical states in future evaluations. According to the diag-
nostic criteria of insomnia defined by the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV), insomnia is related to anxiety and depression,
with many previous neuropsychological studies reporting
that lack of sleep may lead to learning-memory dis-
turbances, low attention with a descending level of
concentration, and mood changes [13]. Regarding the
pathophysiology of insomnia, several studies show that
beta electroencephalogram (EEG) activities increase while
alpha EEG activities decrease in patients with insomnia
[14]. Other studies observed decreasing beta EEG activ-
ities in patients with insomnia after cognitive behavior
therapy or treatment [15]. Some studies of Event Related
Potentials (ERPs) report increasing N1 amplitude and de-
creasing N350 amplitude in insomnia patients compared
to controls; these ERPs’ components are related to hyper-
arousal and inhibition or regulation of arousal [16,17].
Additionally, a recent study shows that HF (high fre-
quency) in heart rate variability (HRV) is more dominant
than LF (low frequency) in patients with insomnia [18].
However, according to one review, there are no consistent
results of HRV in studies of effect in acupuncture treat-
ment, although HRV is a useful tool for observing how
acupuncture treatment affects the autonomic nervous sys-
tem related to sleep cycles [19].
Furthermore, relying on self-report measures - which
are subjective and vulnerable to biases - to verify symp-
tom reporting is inadequate. Changes in psychological,
physiological, and cognitive functions should be ob-
served using more objective methods, such as neuro-
psychological tests and electro-physiological measures.
Methods/Design
Hypothesis
Insomnia patients treated with acupuncture therapy
would have their symptoms more effectively relieved
than patients in a sham control group.
Objectives
1) To examine significant improvement in the
Insomnia Severity Index (ISI), the Pittsburgh Sleep
Quality Index (PSQI), and sleep logs of insomnia
patients [20,21];
2) To compare changes in EEG and HRV brought on
by acupuncture treatment;
3) To compare changes on the Beck Depression
Inventory (BDI), the State-Trait Anxiety Inventory
(STAI), the World Health Organization Quality of
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Korean-Auditory Verbal Learning Test (K-AVLT),
and the Digit Span Test (DS) from pre- to
post-acupuncture treatments [22-26].
Setting
The study will be performed at the Hwabyung/Stress Clinic
in the Kyung Hee University East-West Neo Medical
Center at Gangdong, Seoul, as a single-center, patient-
assessor-blinded, parallel-group randomized controlled
trial. Subjects will be recruited through advertisements
on Internet websites, newspapers, and hospital bulletins.
Subjects interested in participating in the trial shall be
assessed according to inclusion and exclusion criteria by
phone. Subjects who meet those criteria will be asked to
visit the investigation site.
At the site first visit for screening meeting, subjects
will be given more detailed information about the pro-
cedures of the study and asked to provide written
informed consent if they wish to enroll. Candidate sub-
jects will then complete the PSQI, with a score of 6 or
above on the PSQI being used to diagnose subjects as
clinical insomnia patients. At this point, inclusion and
exclusion criteria will be reassessed, with patients satis-
fying those criteria being enrolled and registered into
the clinical trial.
Registered patients shall be provided with a handout
on sleep hygiene education that includes a brief account
by the experimenter. They shall also be instructed to
complete a sleep log for 2 days prior to their second visit
to the center for the baseline evaluation and the first
treatment, in order to see whether they had experienced
insomnia recently and could properly keep their sleep
logs. On the day of the second visit, an expert will check
whether patients have completed their sleep logs cor-
rectly and re-conduct them on their sleep log writing
methods if necessary. The patients will complete their
sleep logs during 2 weeks from the second visit.
On the second visit day for the baseline evaluation and
the first treatment, all patients will also complete the
PSQI, ISI, BDI, STAI, K-AVLT, and the DS, with HRV
measured at baseline (prior to first treatment), after the
last treatment, and at the 1-week follow-up. EEG recor-
dings will be used as objective measures to validate self-
reported insomnia symptoms. ERPs will be measured at
baseline and after the last treatment using an odd-ball
task. Spontaneous EEGs will also be measured at base-
line after the last treatment for spectral analysis. All sub-
jects will complete the WHOQOL-BREF at baseline
and at 1-week follow-up. They will also complete the
Temperament Character Inventory (TCI) at baseline. All
patients will also complete a sleep log every day from
baseline to the 1-week follow-up [27]. The Credibility of
Treatment Rating Scale (CTRS) will be administered toassess the maintenance of blind conditions after the se-
cond treatment [28].
Registered patients shall be randomly divided into the
experimental and sham control groups, with an equal
number of patients assigned to each group. Patients will
then complete either the experimental or sham acupunc-
ture treatment 3 times, with 2- to 3-day intervals, within
1 week.




a. Male or female over 18 under 65 years old
b. Reports clinical symptoms for insomnia and score of
6 or above on the PSQI
c. Demonstrates no problems with communication,
both visual and auditory (reading, writing, hearing,
speaking, and watching)
d. Signed the written informed consent form for the
clinical trial
Exclusion criteria
a. Has taken Western and/or Oriental medicine and/or
dietary supplements in the past 2 weeks for
insomnia
b. Has a severe neural or psychiatric disorder or a
history of major neuropsychiatric disorder
(for example, autism, learning disorder, mental
retardation, and so on)
c. Has received acupuncture for insomnia treatment in
the past month
d. Has infection or inflammation at the acupoints
e. Has a hemorrhagic disease or anticoagulant intake
f. Has a serious physical disorder
g. Has participated in any other clinical trial within a
month of the screening date
h. Pregnancy, breast-feeding, or being a woman of
childbearing age not on a proper method of birth
control
Assessments
All assessments in the trial are shown in Figure 2.
Interventions
In the experimental group, patients will receive needle
acupuncture treatment on 5 specified acupoints (PC6,
SP6, HT7, KI6, and BL62) for 20 minutes. After 20 mi-
nutes, the needles will be removed and intradermal acu-
puncture (IDA) placed at the same points. The smaller
IDA shall be kept attached on the skin for 48 to 72 hours
Figure 1 Study flow chart.
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selves before sleep.
In the control group, all interventions shall be the
same as those of the experimental group except the loca-
tion of the acupoints, substituting them with five shamacupoints. The sham acupoints shall be about 1.0 cm
from the real acupoints in the experimental group and
are spots that do not belong to standard acupoints on
the body and are not suitable for actual acupuncture
based on anatomical and other conditions. IDA will be
Figure 2 Treatment and assessment schedule.
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well with the same instructions as that of the experimen-
tal group.
All acupuncture treatment complies with the Standards
for Reporting Interventions in Clinical Trials of Acupunc-
ture (STRICTA) revised in 2010 (see Table 1) [29].Outcomes
Primary outcome
The primary outcome of this study will be the changes
in the ISI between the baseline, post-treatment assess-
ment, and 1-week follow-up.
The PSQI is an effective self-report questionnaire used
to assess the quality of sleep and sleep disturbances. The
PSQI is comprised of 19 items consisting of the follo-
wing components: subjective sleep quality, sleep latency,
sleep duration, habitual sleep efficiency, sleep distur-
bances, use of sleeping medication, and daytime dys-
function. The ISI is a five-point Likert-scale self-rate
questionnaire designed to assess the nature, severity, and
impact of insomnia, and is widely used to measure re-
sponses to treatment in research studies and clinical
trials.Secondary outcome
Secondary outcome measures refer to scores on the BDI,
STAI, WHOQOL-BREF, K-AVLT, and DS, the weekly
average of the components in the sleep logs during the
2-week period, and changes in EEG and HRV between thebaseline, post-treatment assessment, and 1-week follow-
up (only the EEG was excluded at 1-week follow-up).
The BDI and STAI measure emotional states. The BDI
is a self-report scale used in clinics and research com-
monly for measuring severity of depression through a
21-item multiple-choice questionnaire. The STAI in turn
is a 40-question self-report inventory based on a 4-point
Likert scale that measures each state and trait of anxiety.
Normalized Korean versions of both instruments will be
used in the trial. The WHOQOL-BREF will be used for
measuring quality of life related to psychological health,
social relationships, and environment. It consists of 26
items, a shorter version than the original instrument for
research studies and clinical trials. A Korean version of
this questionnaire will be used.
The sleep log is a diary to be kept by the patients
themselves of their sleeping and waking times as well as
additional sleep-related information. It is a useful tool in
diagnosing insomnia and monitoring whether treatment
is working. Sleep logs include 16 points of information
such as sleep-onset latency, waking after sleep onset,
time in bed, total sleep time, number of awakenings,
sleep quality, and so on.
The K-AVLT is a Korean version of the Auditory Verbal
Learning Test normalized for Koreans and is used to
evaluate verbal learning and memory abilities in terms of
neuropsychological assessment. The DS in turn measures
working memory and attention.
EEGs will be recorded from 8 channels (F3, F4, Fz,
T3, Cz, T4, Pz and electrooculogram) with QEEG-8
Table 1 Interventions details by Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA)
items
Item Details Intervention
1. Acupuncture rationale 1a) Style of acupuncture Traditional needle acupuncture and intradermal
acupuncture
1b) Reasoning for treatment provided based on
historical context, literature sources, and/or consensus
methods, with references where appropriate
Selected traditional acupuncture points on the 12
meridian system based on the systematic review by
Yeung and clinical experiences
1c) Extent to which treatment was varied No variation
2. Details of needling 2a) Number of needle insertions per subject per session
(mean and range where relevant)
Five needle insertions per 1 session
2b) Names (or location if no standard name) of points
used (uni/bilateral)
Neiguan (PC6), Sanyinjiao (SP6), Shenmen (HT7), Zhaohai
(KI6), Shenmai (BL62), all unilateral.
2c) Depth of insertion, based on a specified unit of
measurement or on a particular tissue level
Depth of needle insertion was at least 5 to10 mm and
intradermal acupunctured was 1 to 2 mm
2d) Response sought De-qi sensation felt by practitioner and subject
2e) Needle stimulation No stimulation and just retention without movement
Intradermal acupuncture fixed with skin tape and
subjects educated to self finger-press on them at
nighttime
2f) Needle retention time Twenty-minute retention for needles, intradermal
acupuncture patched 48 to 72 hours until next session
2 g) Needle type (diameter, length, and manufacturer
or material)
Needles: 0.25 × 40 mm, stainless steel (Dong Bang
Medical Co. Ltd, Korea)
Intradermal acupuncture: 0.18 × 1.3 × 1.5 mm, stainless
steel (Dong Bang Medical Co. Ltd, Korea)
3. Treatment regimen 3a) Number of treatment sessions Three sessions
3b) Frequency and duration of treatment sessions Three times per week, interval of 1 to 4 days between
sessions
4. Other components of
treatment
4a) Details of other interventions administered to the
acupuncture group
Sleep hygiene education
4b) Setting and context of treatment, including
instructions to practitioners, and information and
explanations to patients
Same practitioner treats every subject at every session
in the same outpatient clinic
5. Practitioner background 5) Description of participating acupuncturists
(qualification or professional affiliation, years in
acupuncture practice, other relevant experience)
Licensed traditional Korean medicine doctor at the
Kyung Hee East-West Neo Medical Center at Gangdong
with more than 10 years of acupuncture treatment
experience
6. Control or comparator
interventions
6a) Rationale for the control or comparator in the
context of the research question, with sources that
justify this choice
Sham acupuncture points
6b) Precise description of the control or comparison
group. If sham acupuncture or any other type of
acupuncture-like control is used, provide details as for
items 1 to 3 above
Same as intervention group except 2b) and 2d)
2b) No acupuncture points located away from
acupuncture points at least 10 mm
2d) Without De-qi sensation
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lobe (A1) will be used as a reference electrode during data
recording. The electrooculograms (EOG) generated from
eye blinks or movements shall be recorded with an elec-
trode placed approximately 1 cm below the subject’s right
outer eye can thus. Electro-physiological signals will be
amplified (20,000) and filtered (bandpass filter = 0.25 to
50 Hz). EEG signals shall be digitized to 256 Hz.HRV will be recorded by QECG-3(LXC3203, LAXTHA
Inc. Daejeon, Korea) for 5 minutes while the patient main-
tains a sitting posture.Safety assessment
The experiment will ask subjects to report adverse
events (AEs), such as unexpected physical changes or
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phone at other times during the study.
Every adverse event reported by subjects will be de-
scribed in the case report form (CRF). If the adverse
event is severe and associated with the trial, the partici-
pant will be withdrawn from the study and given appro-
priate medical care.
Sample size
Sample size was calculated based on a ratio of 1:1 bet-
ween the experimental and control groups. This sample
size is based on a study that investigated the effect of
acupuncture treatment on insomnia using ISI as a pri-
mary outcome [30]. In that study, the mean change in
ISI between the experimental and control groups was
3.8 and the standard deviation was estimated as the me-
dian between the experimental (SD =4.0) and control
groups (SD =3.2). Based on a two-tailed alpha error of
5% and with a statistical power of 80%, the calculated












Therefore, all 38 participants will be randomly
assigned with 19 subjects in each group, assuming a 20%
dropout rate.
Randomization
An expert will randomly generate a block size (4 or 6)
sequence using Microsoft Excel (Redmond, WA, USA).
After that, with the allocation ratio of the experimental
and control group within each block kept at 1:1, the
expert will randomly generate the numbers 0 (control
group) or 1 (experimental group) through Microsoft
Excel. This expert will not contact any of the patients
during the experiment. Once the expert generates the
random numbers, the expert will seal each number in an
opaque envelope. The expert lets the clinician know
each random number as the clinician calls a patient by
telephone. Two other experts (neuropsychologists) -
who measure the self-reported tests, the psychological
(cognitive) tests, the EEG and HRV - will be blinded.
Only the clinician who treats acupuncture therapy knows
what treatment the patient has been administered, but he
is prohibited from accessing any measurements for out-
comes. Double-blinding is almost impossible due to the
specifications of the acupuncture treatment. Thus, in this
trial, only the neuropsychologist (assessor), the statistical
expert, and patients will be blinded.Statistical method
The primary outcome variable for efficacy analysis is ISI,
and secondary outcomes are the PSQI, BDI, STAI,
WHOQOL-BREF, sleep logs, K-AVLT, DS, EEG, and
HRV. Demographics, sleep logs, ISI, PSQI, K-AVLT,
Digit Span, STAI, TCI, EEG, and HRV will be analyzed
using independent sample t-tests at baseline to deter-
mine equality of the two groups. A chi-square test will
be used to assess sex differences. An efficacy analysis will
be done using both per-protocol and intention-to-treat
analyses.
Independent t-tests between the two groups and a
repeated-measures analysis of variance (ANOVA) will be
used to determine and compare the effect of acupunc-
ture. The factors are treatment (3 levels: pre-, post-
acupuncture and 1-week follow-up) and groups (2 levels:
treatment and sham) and their interaction. The signifi-
cance level was set at P <0.05 and post-hoc analyses were
performed where appropriate.
Monitoring
A qualified clinical trial expert will monitor this study.
This trial in particular will be monitored by Gajin Han,
OMD, PhD, a research professor at the College of Korean
Medicine, Kyung Hee University. Han is a professional
clinical research associate, having completed a formal
training program organized by the Korea National Enter-
prise for Clinical Trials. Monitoring will commence after
the first participant completes the entire period of this
study.
Ethical considerations
The Institutional Review Board (IRB), prior to subject re-
cruitment, has already approved the entire design and pro-
cedure of the clinical trial, CRF, and all measures that will
be used in the study (reference number KHNMC-OH-IRB
2011-015, IRB at Kyung Hee University Gangdong Medical
Center, approved on the 13 September 2012). All subjects
must provide written informed consent prior to study
participation.
The trial will be performed in accordance with the
principles of good clinical practice of the Korean Food
and Drugs Administration and/or the Declaration of
Helsinki 2008.
Discussion
Standards for Reporting Interventions in Clinical Trials
of Acupuncture (STRICTA) were revised in 2010, yet
few studies have rigorously observed these recommenda-
tions. Consequently, the results of many previous studies
likely do not meet standards of objectivity and metho-
dology. In our proposed study, all details such as acu-
points, verification tools, and use of acupuncture needles
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STRICTA standards.
Previous trials of acupuncture treatment have focused
only on subjectively reported symptoms of insomnia. Con-
sequently, they are not able to observe the mechanisms of
acupuncture’s effect on insomnia. In the present trial, HRV
will be used to assess changes in the autonomic nervous
system and EEG will be used to assess changes in brain ac-
tivity in real time. These measures will objectively examine
physiological changes due to acupuncture in real time.
Depression, anxiety, and decline in cognitive functions
are the main consequences of chronic insomnia as
reported by many previous studies, and such symptoms
ultimately degrade quality of life. The effect of acupunc-
ture on insomnia will be verified at multi-dimensional
levels in this trial, assessing psychological and emotional
states, cognitive functions, and quality of life, allowing us
to observe how the relief of insomnia symptoms due to
acupuncture treatment improves patients’ quality of life.
In the trial, we will test the intradermal acupuncture
method particularly for enhancing the effectiveness of
acupuncture for insomnia. The acupuncture is stimu-
lated every night by subjects applying it continuously on
their own, even at home.
The design of the control group in studies verifying the
effect of acupuncture treatment is always an issue. For
this blind-controlled study, STRICTA suggests active
acupuncture control, penetrating needle control, or non-
penetrating sham needling control. The present proposed
trial will use ‘sham’ acupuncture points as active acupunc-
ture control. However, it is possible that sham acupunc-
ture may lead to improvement. Such a methodological
limitation should be improved upon in future studies. A
double-blind trial is not possible because of the particular
treatment method of the controls. This limitation will be
addressed with an evaluation by an experimenter who is
not involved in the treatment. Furthermore, there are limi-
tations associated with the lack of polysomnographic data
due to constraints of time, expense, and space in the hos-
pital, as the present trial is still a pilot study. The actigra-
phy and polysomnography are objective tools for assessing
insomnia and are also highly recommended, but many
other studies have used them as secondary outcomes
while still others did not use actigraphy and/or poly-
somnography as outcomes at all [31-33,10,11]. However,
polysomnography will be assessed in our planned future
expanded trials.
Trial status
This clinical trial is currently recruiting participants.
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